Five digital and connected health technologies tackling some of Australia’s most pressing health challenges will share in a total funding injection of up to $9 million across two stages after being successfully accepted into the latest intake of the country’s leading digital and connected health accelerator program, ANDHealth+.

ANDHealth+ is supported by a $33 million BioMedTech Incubator grant from the Australian Government’s Medical Research Future Fund (MRFF) Medical Research Commercialisation Initiative. It is a non-equity-taking accelerator and incubator program that connects digital and connected health companies with proven international and Australian experts and tranched, milestone-based non-dilutive funding to address critical commercialisation hurdles.

This new funding will support Australian startups Australis Scientific (NSW), Corcillum (SA), Earflo (WA), Kraken Coding (NSW but founded in NT) and MoreGoodDays (VIC) to scale their businesses to solve health challenges with breakthrough innovations in cardiovascular disease, urology, chronic pain, paediatric ear infections, as well as inefficiencies in clinical decision making impacting patient care.  

The first stage will see these five companies share a $1.5 million funding pool, with the potential to move through to the second stage of the program and share in a larger pool of up to $7.5 million to complete large scale projects that address key commercialisation risks, enabling the companies to be primed for follow-on institutional investment and/or enterprise customer uptake.  

ANDHealth Chief Executive Bronwyn Le Grice said this intake was the program’s most competitive yet, receiving more than 90 applications, reflecting the increasing challenges facing Australian digital and connected health founders around accessing capital in the sector.

“Having the first South Australian company and the first company founded in the Northern Territory join ANDHealth+ is a reflection of the significant growth in the sector here and a powerful signal that Australia’s digital and connected health opportunity truly is national, not concentrated in just one or two states,” Ms Le Grice said.

The digital and connected health sector in Australia has been growing at a compound annual growth rate (CAGR) of 55 per cent since 2018. The number of companies in Australia has almost doubled in the past three years and now sits at over 1375 companies.

“Globally, the sector in projected to grow to US$946 billion by 2030 and Australia is home to some of the most promising and innovative digital and connected health startups. We are well-positioned to deliver substantive economic and health benefits to all Australians as well as to patients around the globe,” Ms Le Grice said.

These digital and connected health companies will receive specialised, hands-on project management and support services to technically and commercially de-risk their businesses. Additionally, ANDHealth’s global partner and expert network will enable the companies to access established connections and critical market intelligence required to successfully enter international markets.  

The successful applicants for this, the fifth, intake of ANDHealth+ are:

  • Australis Scientific: Its ‘Confidanz Smart Patch’ adapts percutaneous tibial nerve stimulation for home use in treating overactive bladder. It combines guided placement, microneedle electrodes, and clinician-connected software to provide consistent therapy remotely, reducing clinic dependence and improving accessibility and adherence.
  • Corcillum: Its software-based coronary digital twin uses standard angiography images to model blood flow, vessel mechanics, and plaque behaviour without any extra invasive procedures. The result is rapid, non-invasive physiological and plaque analytics that improve diagnosis accuracy and efficiency in coronary care.
  • Earflo: Its child-friendly, non-invasive device uses swallow-synchronised air pressure to release middle-ear fluid and restore hearing. Its connected app supports device compliance, engagement, and monitoring, enabling effective at-home treatment and reducing the need for surgery.
  • Kraken Coding: Its ‘Clinical Branches’ software converts clinical guidelines into interactive, patient-specific decision pathways for use at the point of care. Its AI algorithm structures key decision steps, helping clinicians apply guidelines more consistently and efficiently, especially in high-pressure settings.
  • MoreGoodDays: Its digital chronic pain-management and recovery platform delivers evidence-based multidisciplinary care to help people living with persistent musculoskeletal pain from home, including chronic back and neck pain, whiplash, fibromyalgia and other long-term pain issues. 

“Independent economic assessment shows ANDHealth+ outperforms other leading Australian accelerators programs across health and technology across all major outcomes. To date, the 28 companies that have participated in ANDHealth+ have raised over $203 million in follow-on funding, generated over $90 million in new revenue, created 535 new jobs, and impacted over 4.1 million patients,” Ms Le Grice said.

For every dollar invested by the government, ANDHealth+ companies have raised $22.20 in new capital and generated $7.60 in new revenues. For $1 million invested into ANDHealth+, 56 high-value R&D jobs were created – which is 14 times more than the International Monetary Fund’s benchmark of four jobs.  

Applications for the next intake of the ANDHealth+ program are expected to open in late July 2026.